The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Oct 30, 2026
During the third quarter of 2026, mid-cap equities faced significant pressure as the Russell Midcap Growth Index declined 5.84%, trailing value peers. The fund closed the period managing $4.51 billion in total net assets across 97 holdings. The investment team responded to macro volatility and rising discount rates by prudently trimming exposure to cyclical sectors, maintaining a selective posture focused on companies with idiosyncratic drivers capable of outgrowing their underlying end markets. The macroeconomic environment was shaped by benchmark 10-year US Treasury yields surging past 5% following hawkish Federal Reserve rate hikes and geopolitical friction in the Middle East elevating energy prices. While near-term market sentiment showed signs of AI fatigue and data center infrastructure drew heightened political scrutiny ahead of midterm elections, secular drivers across enterprise technology remained robust. Elsewhere, the healthcare sector contended with regulatory drug pricing policy and Medicaid disenrollment headwinds, balanced by solid biotechnology and medical device transaction volume. Portfolio performance was supported by strong contributions from top holdings, including Natera, Cloudflare, Snowflake, and Twilio, each benefiting from accelerating enterprise software and diagnostic demand. Conversely, Dycom Industries, RB Global, Viking, Carpenter Technology, and Axon Enterprise detracted from performance due to project timing deferrals, weather-related waterway disruptions, and valuation multiple compression despite resilient operational backlogs.
Invest in durable, high-quality mid-cap growth companies possessing strong secular tailwinds, resilient balance sheets, and the ability to outgrow their end markets regardless of broader economic headwinds.
Declining equity valuations against a backdrop of healthy corporate profits and economic resilience have set the stage for a possible year-end seasonal rally. The team expects interest rates and energy prices to dictate cyclical performance while long-term secular growth remains robust across AI infrastructure and innovative healthcare.
Neutral / Balanced
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Carillon Eagle Mid Cap Growth Fund or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.